Corporate Tech Investors

WuXi Biologics

WuXi Biologics is a corporate VC investing group that makes strategic investments in technologies that align with its strategic interests.

Venture Investor Overview

Contact Information

Background Information

Overview

WuXi Biologics (stock code: 2269.HK), a Hong Kong-listed company, is a leading global open-access biologics technology platform offering end-to-end solutions to empower organizations to discover, develop and manufacture biologics from concept to commercial manufacturing. Our company history and achievements demonstrate our commitment to providing a truly ONE-stop service offering and strong value proposition to our global clients.

Profile

Social Media

Company News

Facebook

YouTube

Last Transaction

10/1/2020

Transaction History

Our records indicate that WuXi Biologics invested in the VC transactions listed below. Dollar amounts are for the entire raise, which may include other investors.

Investor Contacts

Title

Name

Email & Social

Chief Executive Officer

Zhisheng Chen

        

Funds

No fund closings have been recorded for this company.

Portfolio Companies

WuXi Biologics has invested in the companies below, according to our database records. If we are missing a portfolio company, please let us know.

Browse more corporate investors:

WuXi AppTec | WuXi NextCODE

Share this article

About Our List of Corporations Investing in Tech Companies

Our corporate equity investment data comes from VentureDeal.com, a leading provider of corporate tech investing transaction data.

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary